Biomarker detection using layered receptor and electrode configuration
Herein disclosed is configuring a layered receptor with at least one layer comprising graphene oxide and an biomarker binding layer configured to bind with a targeted biomarker, connecting a working electrode comprising carbon nanotubes (CNT) and a reference electrode to the layered receptor, and detecting events comprising the targeted biomarker binding layer with the biomarker binding layer, by measuring changes in impedance to a plurality of frequencies of an alternating current voltage signal applied through a patient's body fluid between the working electrode and the reference electrode. The layered receptor may further comprise a plurality of self-assembled layers, comprising, in sequence, a layer abutting the CNT and comprising a polymer and metal nanoparticles, a layer comprising an organosulfur, the graphene oxide layer and the biomarker binding layer. The biomarker binding layer may comprise Syn-211, LB509 or 5G4. The targeted biomarker may be alpha-synuclein. An implementation may report biomarker concentrations in real-time based on detected binding events.
1 . A method for measuring biomarker levels comprising:
configuring a layered receptor with a plurality of self-assembled layers in sequence, wherein the layers consist of in sequence:
(a) a layer with at least one metal nanoparticle and a polymer that abuts a carbon nanotube (CNT) working electrode,
(b) a layer with at least one cysteamine layer,
(c) at least one graphene oxide layer, and
(d) at least one biomarker binding layer configured to bind with a targeted biomarker;
connecting the CNT working electrode and a reference electrode to the layered receptor; and
detecting events consisting of the targeted biomarker binding with the biomarker binding layer by measuring changes in impedance of frequencies from 0.5 Hz to 100 kHz of an alternating current voltage signal applied through a patient's body fluid between the working electrode and the reference electrode.
2 . The method of claim 1 , further comprising calibrating the changes in impedance with known biomarker concentrations.
3 . The method of claim 1 , wherein the polymer in the metal nanoparticle polymer layer comprises a biocompatible polymer.
4 . The method of claim 3 , wherein the polymer in the metal nanoparticle polymer layer is selected from at least one of monemethylamine (MMA), dimethylamine (DMA), trimethylamine (TMA), methylamine hydrochloride, and 1-pyrene-methylamine (PMA).
5 . The method of claim 4 , wherein the polymer in the metal nanoparticle polymer layer is PMA.
6 . The method of claim 3 , wherein the metal nanoparticle comprises gold.
7 . The method of claim 3 , wherein the metal nanoparticle comprises silver.
8 . The method of claim 1 , wherein the method further comprises configuring the biomarker binding layer with an antibody, or antibody fragment thereof, wherein the antibody, or antibody fragment is at least 60% similar to at least one of SEQ ID. NOs. 1-4.
9 . The method of claim 1 , wherein the method further comprises configuring the antibody layer with an antibody, or antibody fragment thereof, wherein a binding region of the antibody, or antibody fragment thereof, is at least 70% similar to at least one of SEQ ID. NOs. 1-4.
10 . The method of claim 1 , wherein the method further comprises configuring the antibody layer with an antibody, or antibody fragment thereof, wherein a binding region of the antibody, or antibody fragment thereof, is at least 90% similar to at least one of SEQ ID. NOs. 1-4.
11 . A biosensor comprising:
a carbon nanotube (CNT) working electrode, and
a layered receptor with a plurality of self-assembled layers in sequence, wherein the layers in sequence consist of:
a polymer and metal nanoparticle layer that abuts the CNT working electrode,
a cysteamine layer,
a graphene oxide layer, and
an antibody layer.
12 . The biosensor of claim 11 , further comprising a reference electrode.
13 . The biosensor of claim 12 , further comprising a counter electrode.
14 . The biosensor of claim 13 , wherein one or more of the reference electrode or counter electrode are a carbon nano tube.
15 . The biosensor of claim 12 , wherein both of the working electrode and the reference electrode is a carbon nano tube.
16 . The biosensor of claim 12 , further comprising a sampling apparatus.
17 . The biosensor of claim 11 , wherein the polymer comprises 1-pyrene-methylamine (PMA), the metal nanoparticle is chosen from a group of gold and silver, and the antibody is an antibody, or antibody fragment thereof, that binds alpha-synuclein.